Clinical Trial Update: Efficacy and Safety of Adalimumab in Patients With Rheumatoid Arthritis in Routine Clinical Practice

View source ↗

Summary

This clinical trial update reports real-world efficacy and safety data for adalimumab in patients with rheumatoid arthritis treated in routine clinical practice…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2014-04-08